Related Experiment Video
Updated: Mar 9, 2026

10:07
Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
68.9K
PPARβ in macrophages and atherosclerosis
G Chinetti-Gbaguidi1, B Staels2
1Université Côte d'Azur, CHU, CNRS, Inserm, IRCAN, France.
Biochimie
|December 25, 2016
Summary
Peroxisome proliferator-activated receptor beta (PPARβ) regulates cholesterol metabolism and inflammation in macrophages, key cells in atherosclerosis development. Understanding PPARβ
Area of Science:
- Cardiovascular Biology
- Immunology
- Molecular Endocrinology
Background:
- Macrophages are crucial in atherosclerosis pathogenesis, regulating lipid uptake and inflammation.
- Foam cell formation via lipid accumulation is a hallmark of atherosclerotic lesions.
- Macrophages exhibit diverse phenotypes (M1/M2) influencing inflammatory responses.
Purpose of the Study:
- To review the role of Peroxisome Proliferator-Activated Receptor beta (PPARβ) in macrophage biology.
- To elucidate how PPARβ influences lipid metabolism, inflammation, and phagocytosis in macrophages.
- To discuss the impact of PPARβ on atherosclerosis development and progression.
Main Methods:
- Literature review of studies investigating PPARβ in macrophages.
- Analysis of research on PPARβ's effects on lipid handling and inflammatory pathways.
- Examination of PPARβ's role in efferocytosis and its implications for atherosclerosis.
Main Results:
- PPARβ plays a multifaceted role in controlling macrophage lipid metabolism and inflammatory status.
- PPARβ influences cholesterol homeostasis and the resolution of inflammation within macrophages.
- Evidence suggests PPARβ's involvement in phagocytosis of apoptotic cells, impacting lesion development.
Conclusions:
- PPARβ is a key regulator of macrophage function relevant to atherosclerosis.
- Targeting PPARβ may offer therapeutic strategies for cardiovascular diseases.
- Further research is needed to clarify species-specific effects and optimize therapeutic interventions.
Related Concept Videos
Inflammation
63.3K
Overview
63.3K
Atherosclerosis I: Introduction
1.7K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.7K
Cholesterol: Significance and Regulation
1.8K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.8K
Peripheral Artery Disease I: Introduction
521
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
521
Atherosclerosis III: Management
541
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541
Coronary Artery Disease II: Pathophysiology
857
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
857

